Published in J Crohns Colitis on September 13, 2014
Impact of Fecal Microbiota Transplantation in Ulcerative Colitis (REBALANCE-UC) | NCT03483246
Neurocognitive Effects of FMT in MDD Patients With and Without IBS | NCT05174273
The gut microbiota and host health: a new clinical frontier. Gut (2015) 1.91
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology (2015) 1.42
Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med (2016) 1.08
Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders. BMJ Open Gastroenterol (2016) 1.02
Microbial activities and intestinal homeostasis: A delicate balance between health and disease. Cell Mol Gastroenterol Hepatol (2015) 1.00
Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.99
Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation. Clin Ther (2015) 0.95
Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis. J Transl Med (2015) 0.94
Review: Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases. Arthritis Rheumatol (2016) 0.93
Serial fecal microbiota transplantation alters mucosal gene expression in pediatric ulcerative colitis. Am J Gastroenterol (2015) 0.93
Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives. Clin Endosc (2016) 0.90
Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients. Intest Res (2017) 0.85
Gut microbiome diversity in acute infective and chronic inflammatory gastrointestinal diseases in North India. J Gastroenterol (2016) 0.84
Navigating the Microbial Basis of Inflammatory Bowel Diseases: Seeing the Light at the End of the Tunnel. Gut Liver (2016) 0.84
Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches. Gastroenterology (2016) 0.83
Fecal microbiota transplantation: in perspective. Therap Adv Gastroenterol (2016) 0.82
The interplay between the intestinal microbiota and the immune system. Clin Res Hepatol Gastroenterol (2014) 0.81
Fecal microbiota transplantation in patients with slow-transit constipation: A randomized, clinical trial. PLoS One (2017) 0.81
Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases. Inflamm Bowel Dis (2016) 0.80
Pglyrp-Regulated Gut Microflora Prevotella falsenii, Parabacteroides distasonis and Bacteroides eggerthii Enhance and Alistipes finegoldii Attenuates Colitis in Mice. PLoS One (2016) 0.80
Step-up fecal microbiota transplantation (FMT) strategy. Gut Microbes (2016) 0.79
Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2016) 0.79
Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients. Int J Mol Sci (2016) 0.79
Effects of Fecal Microbial Transplantation on Microbiome and Immunity in Simian Immunodeficiency Virus-Infected Macaques. J Virol (2016) 0.79
IBS and IBD - separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol (2016) 0.79
Nutritional Keys for Intestinal Barrier Modulation. Front Immunol (2015) 0.79
Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Dig Dis Sci (2017) 0.79
The resilience of the intestinal microbiota influences health and disease. Nat Rev Microbiol (2017) 0.78
Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clin Microbiol Rev (2017) 0.78
Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease. Clin Transl Immunology (2016) 0.78
Gut microbiome as a novel cardiovascular therapeutic target. Curr Opin Pharmacol (2016) 0.78
Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation. Yale J Biol Med (2016) 0.78
Gut Microbiota in Cardiovascular Health and Disease. Circ Res (2017) 0.77
Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease. World J Gastroenterol (2016) 0.77
Colonic transendoscopic enteral tubing: A novel way of transplanting fecal microbiota. Endosc Int Open (2016) 0.77
Gut inflammation and microbiome in spondyloarthritis. Rheumatol Int (2015) 0.77
Involvement of Reduced Microbial Diversity in Inflammatory Bowel Disease. Gastroenterol Res Pract (2016) 0.76
Fecal microbiota transplantation in inflammatory bowel disease: the quest for the holy grail. Mucosal Immunol (2016) 0.76
The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation. Front Cell Infect Microbiol (2016) 0.76
The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target? Curr Opin Rheumatol (2016) 0.76
Fecal Microbiota Transplantation for Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y) (2016) 0.76
Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature. Dig Dis Sci (2017) 0.76
Is there a potential role of fecal microbiota transplantation in the treatment of inflammatory bowel disease? Intest Res (2017) 0.75
Profiling Living Bacteria Informs Preparation of Fecal Microbiota Transplantations. PLoS One (2017) 0.75
Inflammatory bowel disease: Traditional knowledge holds the seeds for the future. World J Gastrointest Pharmacol Ther (2015) 0.75
The Human Microbiome and the Immune System: An Ever Evolving Understanding. J Clin Cell Immunol (2014) 0.75
Diet and microbiota in inflammatory bowel disease: The gut in disharmony. World J Gastroenterol (2017) 0.75
Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y) (2015) 0.75
Understanding Luminal Microorganisms and Their Potential Effectiveness in Treating Intestinal Inflammation. Inflamm Bowel Dis (2016) 0.75
Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies. Immune Netw (2017) 0.75
Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders. J Neurogastroenterol Motil (2017) 0.75
Fecal microbiota transplantation for refractory Crohn's disease. Intest Res (2017) 0.75
Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis. World J Gastroenterol (2017) 0.75
Sensitivity to oxazolone induced dermatitis is transferable with gut microbiota in mice. Sci Rep (2017) 0.75
The Microbiome and Sustainable Healthcare. Healthcare (Basel) (2015) 0.75
Perceptions of fecal microbiota transplantation for Clostridium difficile infection: factors that predict acceptance. Ann Gastroenterol (2016) 0.75
Microbiota: Reseeding the gut. Nature (2017) 0.75
Fecal microbiota transplantation is a rescue treatment modality for refractory ulcerative colitis. Medicine (Baltimore) (2017) 0.75
MAHMI database: a comprehensive MetaHit-based resource for the study of the mechanism of action of the human microbiota. Database (Oxford) (2017) 0.75
The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therap Adv Gastroenterol (2016) 0.75
Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Gut Microbes (2017) 0.75
Human microbiome: From the bathroom to the bedside. World J Gastrointest Pathophysiol (2015) 0.75
Embracing the gut microbiota: the new frontier for inflammatory and infectious diseases. Clin Transl Immunology (2017) 0.75
Eosinophilic esophagitis: What can we learn from Crohn's disease? United European Gastroenterol J (2016) 0.75
A benign helminth alters the host immune system and the gut microbiota in a rat model system. PLoS One (2017) 0.75
Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis. J Gastroenterol (2016) 0.75
16S rDNA analysis of the effect of fecal microbiota transplantation on pulmonary and intestinal flora. 3 Biotech (2017) 0.75
Human Gut Microbiota: Toward an Ecology of Disease. Front Microbiol (2017) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37
Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med (2013) 20.65
Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol (2013) 4.46
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology (2003) 4.40
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut (2004) 3.80
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut (2004) 3.01
Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol (2009) 2.92
Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol (2013) 2.85
Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr (2013) 2.57
The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology (2011) 2.41
Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children. Aliment Pharmacol Ther (2014) 2.37
Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol (2003) 2.30
Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol (2014) 2.21
Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome? Med J Aust (1989) 2.16
Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther (2012) 2.11
Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis (2013) 1.79
Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet (1989) 1.76
Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol (2010) 1.62
Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis (2011) 1.42
Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol (2015) 1.33
Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn's disease. World J Gastroenterol (2013) 1.24
Curbing our enthusiasm for fecal transplantation in ulcerative colitis. Am J Gastroenterol (2013) 0.96
Relevance of commensal microbiota in the treatment and prevention of inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.92